Ausgabe 2/2024
Inhalt (9 Artikel)
PARP Inhibitors in Breast Cancer: a Short Communication
Gordon R. Daly, Maen Monketh AlRawashdeh, Jason McGrath, Gavin P. Dowling, Luke Cox, Sindhuja Naidoo, Damir Vareslija, Arnold D. K Hill, Leonie Young
Appendiceal Neuroendocrine Neoplasms: an Update for 2023
Pernille Holmager, Seppo W. Langer, Andreas Kjaer, Lene Ringholm, Rajendra Singh Garbyal, Carsten Palnæs Hansen, Mikkel Andreassen, Ulrich Knigge
Sarcopenia and Neuroendocrine Neoplasms
Dominique Clement, Sarah Brown, Monique V. Leerdam, Margot Tesselaar, John Ramage, Rajaventhan Srirajaskanthan
Prolymphocytic Leukaemia: an Update on Biology and Treatment
Dima El-Sharkawi, Claire Dearden
Chronic Lymphocytic Leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease
Janina Stumpf, Othman Al-Sawaf
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival
Catherine Powers-James, Meroë Morse, Santhosshi Narayanan, Lois Ramondetta, Gabriel Lopez, Richard Wagner, Lorenzo Cohen
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours
Nina Fuller-Shavel, Jonathan Krell
Germline Mutations and Ancestry in Prostate Cancer
Eudoxie Bataba, Kevin Babcock, Kathryn A. Isensee, Binil Eldhose, Indu Kohaar, Gregory T. Chesnut, Albert Dobi